Literature DB >> 16169088

To combine or not to combine? A literature review of antidepressant combination therapy.

Seetal Dodd1, David Horgan, Gin S Malhi, Michael Berk.   

Abstract

OBJECTIVE: Treatment resistant depression is a common clinical problem and a major public health concern. The use of antidepressant combinations to overcome treatment resistance, while somewhat controversial, is a popular strategy in practice. This paper reviews published trials on combination antidepressants with a view to inform clinical practice.
METHOD: A systematic but selective review of the published literature was conducted using EMBASE, PSYCHLIT and MEDLINE with relevant search terms.
RESULTS: A number of trials suggesting efficacy of combination antidepressants were found. These are incorporated into a number of treatment guidelines for the management of treatment refractory depression. Clinicians should be cautious regarding pharmacokinetic and pharmacodynamic interactions, including the serotonin syndrome, however combination strategies are an effective option.
CONCLUSIONS: Many antidepressants can be usefully combined especially if they engage separate mechanisms of action. Clinically, antidepressant combinations provide a useful resort in otherwise treatment resistant individuals. However, much further research is needed to determine relative efficacy and determine long term outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169088     DOI: 10.1016/j.jad.2005.08.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  Antidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia.

Authors:  Chenkun Wang; Sujuan Gao; Hugh C Hendrie; Joe Kesterson; Noll L Campbell; Anantha Shekhar; Christopher M Callahan
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

2.  An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.

Authors:  Jeremy Barowsky; Thomas L Schwartz
Journal:  Psychiatry (Edgmont)       Date:  2006-07

3.  Quetiapine augmentation in treatment-resistant depression: a naturalistic study.

Authors:  Marina Sagud; Alma Mihaljević-Peles; Dorotea Mück-Seler; Miro Jakovljević; Nela Pivac
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

4.  Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study.

Authors:  Luca Pasina; Sarah Astuto; Laura Cortesi; Mauro Tettamanti; Carlotta Franchi; Alessandra Marengoni; Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

Review 5.  Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients.

Authors:  Jonathan Henssler; Tom Bschor; Christopher Baethge
Journal:  Can J Psychiatry       Date:  2016-01-01       Impact factor: 4.356

6.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

7.  Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan J Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-15       Impact factor: 5.270

Review 8.  [Pharmacological therapy for therapy-resistant depression. New developments].

Authors:  A Tadić; K Lieb
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

9.  Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study.

Authors:  Yi-Chih Chen; Chih-Ken Chen; Liang-Jen Wang
Journal:  BMC Psychiatry       Date:  2012-09-29       Impact factor: 3.630

10.  Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.

Authors:  Jan Wolff; Pamela Reißner; Gudrun Hefner; Claus Normann; Klaus Kaier; Harald Binder; Christoph Hiemke; Sermin Toto; Katharina Domschke; Michael Marschollek; Ansgar Klimke
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.